Keyword: healthcare

News

Bayer Strikes Deal for Chinese Herbal Medicines Producer

28.02.2014 - In a deal expected to close in the second half of 2014, Bayer has said it will buy privately held Dihon Pharmaceutical Group, a maker of traditional herbal Chinese medicines (TCM)...

News

Bayer, Novartis said to Eye Merck & Co consumer health unit

21.02.2014 - A handful of consumer and healthcare companies including Germany's Bayer and Switzerland's Novartis are exploring a deal for Merck & Co's consumer healthcare business, people...

Sites & Services

ASEAN Harmonization

12.02.2014 - Economic Growth - The Association of Southeast Asian Nations (ASEAN) - comprised of Malaysia, Burma, the Philippines, Singapore, Thailand, Vietnam, Brunei, Cambodia, Indonesia...

News

Kemal Malik appointed Bayer AG Board of Management member with responsibility for Innovation

20.12.2013 - The Supervisory Board of Bayer AG appointed Kemal Malik (51) to the Board of Management of Bayer AG effective February 1, 2014. Malik has been a member of the Bayer HealthCare...

News

Bayer Preparing A Bid For Norwegian Drug Partner Algeta

26.11.2013 - German pharmaceutical group Bayer is preparing a bid to acquire Algeta, its partner for its prostate cancer treatment Xofigo, a German newspaper reported on Tuesday. The...

News

Germany's Merck Sees Long-Term Growth in Cancer Drug Erbitux

07.10.2013 - German healthcare company Merck expects to get a long-term boost from study results in June that showed its main cancer drug Erbitux has an edge over rival product Avastin. Erbitux...

Logistics & Supply Chain

Interview with Angelos Orfanos, DHL: Life Science Demands Advanced Infrastructure

03.06.2013 - Logistics - Globalization, outsourcing and a trend towards generics and biopharmaceuticals are some of the key factors shaping todays supply chains for the life sciences and...

News

Drugmakers Face More Scrutiny of Discordant U.S. Prices

11.05.2013 - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...